Ingle JN - Search Results

1

TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

Asiedu MK, Ingle JN, Behrens MD, Radisky DC, Knutson KL. Asiedu MK, et al. Among authors: ingle jn. Cancer Res. 2011 Jul 1;71(13):4707-19. doi: 10.1158/0008-5472.CAN-10-4554. Epub 2011 May 9. Cancer Res. 2011. PMID: 21555371 Free PMC article.

2

Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.

Reinholz GG, Getz B, Sanders ES, Karpeisky MY, Padyukova NSh, Mikhailov SN, Ingle JN, Spelsberg TC. Reinholz GG, et al. Among authors: ingle jn. Breast Cancer Res Treat. 2002 Feb;71(3):257-68. doi: 10.1023/a:1014418017382. Breast Cancer Res Treat. 2002. PMID: 12002344

3

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD. Witzig TE, et al. Among authors: ingle jn. Clin Cancer Res. 2002 May;8(5):1085-91. Clin Cancer Res. 2002. PMID: 12006523

4

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.

Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, Wu K, Wadum L, Couch VL, Sellers TA, Schaid D, Slezak J, Fredericksen Z, Ingle JN, Hartmann L, Jenkins RB, Couch FJ. Sinclair CS, et al. Among authors: ingle jn. Cancer Res. 2002 Jul 1;62(13):3587-91. Cancer Res. 2002. PMID: 12097257

5

Estrogen as therapy for breast cancer.

Ingle JN. Ingle JN. Breast Cancer Res. 2002;4(4):133-6. doi: 10.1186/bcr436. Epub 2002 May 15. Breast Cancer Res. 2002. PMID: 12100736 Free PMC article.

6

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

Reinholz MM, Iturria SJ, Ingle JN, Roche PC. Reinholz MM, et al. Among authors: ingle jn. Breast Cancer Res Treat. 2002 Jun;74(3):255-69. doi: 10.1023/a:1016339120506. Breast Cancer Res Treat. 2002. PMID: 12206515

7

Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.

Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, Roche PC, Spelsberg TC. Reinholz MM, et al. Among authors: ingle jn. Breast Cancer Res Treat. 2004 Jul;86(1):75-88. doi: 10.1023/B:BREA.0000032926.74216.7d. Breast Cancer Res Treat. 2004. PMID: 15218362

8

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ. Lafky JM, et al. Among authors: ingle jn. Cancer Res. 2005 Apr 15;65(8):3059-62. doi: 10.1158/0008-5472.CAN-05-0067. Cancer Res. 2005. PMID: 15833834

9

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL. Reinholz MM, et al. Among authors: ingle jn. Clin Cancer Res. 2005 May 15;11(10):3722-32. doi: 10.1158/1078-0432.CCR-04-1483. Clin Cancer Res. 2005. PMID: 15897569

10

Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.

Rao RD, Holtan SG, Ingle JN, Croghan GA, Kottschade LA, Creagan ET, Kaur JS, Pitot HC, Markovic SN. Rao RD, et al. Among authors: ingle jn. Cancer. 2006 Jan 15;106(2):375-82. doi: 10.1002/cncr.21611. Cancer. 2006. PMID: 16342250 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters